Urogen Pharma

UroGen Pharma is a biopharmaceutical company focused on developing innovative solutions for urological and uro-oncological diseases. They make money by commercializing proprietary therapies, including Jelmyto, their flagship product for treating low-grade upper tract urothelial cancer. Founded in 2004, UroGen has a history of leveraging its unique RTGel technology to enhance drug delivery and efficacy, positioning itself as a leader in the urology space.

Recent Posts by Urogen Pharma

1-12 of 12